Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine neuroprotection in RRMS
NCT00917839Phase 2Unknown
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lamotrigine in relapsing-remitting multiple sclerosis (RRMS). Status: unknown.
02
Drugs
lamotrigine
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00917839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917839.